PFKFB3 and Sepsis: Furthermore, the pharmacological inhibition of glycolysis by targeting PFKFB3 has been associated with a decrease in mortality, positioning PFKFB3 as a promising therapeutic target for mitigating excessive inflammation in sepsis.